Early Diagnosis of AD - More important than ever before!

Today the Alzheimer's world received some promising news.

"Alzheimer's drug lecanemab hailed as momentous breakthrough"

"The first drug to slow the destruction of the brain in Alzheimer's has been heralded as momentous.

The research breakthrough ends decades of failure and shows a new era of drugs to treat Alzheimer's - the most common form of dementia - is possible.

Yet the medicine, lecanemab, has only a small effect and its impact on people's daily lives is debated.

And the drug works in the early stages of the disease, so most would miss out without a revolution in spotting it." - https://www.bbc.com/news/health-63749586

We are always asked, what difference having one of the most accurate and early diagnostic blood test for Alzheimer's could make. Now more than ever we are confident to direct that question towards studies like these. The possibility of enrolment to promising clinical trials like that with Lecanemab definitely opens up new avenues for the success of Duritect-AD. We at Durin Technologies are excited and re-invigorated about the real world impact that Lecanemab may bring.

How has Alzheimer's affected your family? What are your questions about the disease and early diagnosis? You can get in touch by emailing info@durintechnologies.com.

Learn more about Duritect - AD here.